KELLY BLISS: Open Payments
NPI 1295812477 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,708 in 23 payments from 3 companies in 2025. Trend: 2023 $5,205 · 2024 $524 · 2025 $6,708
Speaker / faculty: $6,101Food & beverage: $580Education: $27
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 21 | $6,643 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: ABILIFY MAINTENA, ABILIFY ASIMTUFII, REXULTI, COBENFY.
Industry payments across WA — which companies pay providers there.
